194 related articles for article (PubMed ID: 24656524)
1. Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study.
Davies SJ; Mulsant BH; Flint AJ; Rothschild AJ; Whyte EM; Meyers BS;
Compr Psychiatry; 2014 Jul; 55(5):1069-76. PubMed ID: 24656524
[TBL] [Abstract][Full Text] [Related]
2. Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.
Østergaard SD; Meyers BS; Flint AJ; Mulsant BH; Whyte EM; Ulbricht CM; Bech P; Rothschild AJ;
J Affect Disord; 2014 May; 160():68-73. PubMed ID: 24439830
[TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).
Meyers BS; Flint AJ; Rothschild AJ; Mulsant BH; Whyte EM; Peasley-Miklus C; Papademetriou E; Leon AC; Heo M;
Arch Gen Psychiatry; 2009 Aug; 66(8):838-47. PubMed ID: 19652123
[TBL] [Abstract][Full Text] [Related]
4. The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.
Bingham KS; Rothschild AJ; Mulsant BH; Whyte EM; Meyers BS; Banerjee S; Szanto K; Flint AJ;
J Clin Psychiatry; 2017; 78(8):1149-1154. PubMed ID: 28445632
[TBL] [Abstract][Full Text] [Related]
5. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.
Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Alexopoulos GS; Rudorfer MV; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Mulsant BH;
JAMA; 2019 Aug; 322(7):622-631. PubMed ID: 31429896
[TBL] [Abstract][Full Text] [Related]
6. Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression.
Victoria LW; Whyte EM; Butters MA; Meyers BS; Alexopoulos GS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ
Am J Geriatr Psychiatry; 2017 Jun; 25(6):672-679. PubMed ID: 28285771
[TBL] [Abstract][Full Text] [Related]
7. SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
Davies SJ; Mulsant BH; Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Kirshner MM; Sorisio D; Pollock BG; Bies RR;
Hum Psychopharmacol; 2016 May; 31(3):252-5. PubMed ID: 27060853
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Bingham KS; Whyte EM; Meyers BS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ;
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1270-1275. PubMed ID: 26560512
[TBL] [Abstract][Full Text] [Related]
9. Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial.
Flint AJ; Iaboni A; Mulsant BH; Rothschild AJ; Whyte EM; Meyers BS;
Am J Geriatr Psychiatry; 2014 Apr; 22(4):332-6. PubMed ID: 23642462
[TBL] [Abstract][Full Text] [Related]
10. [Love, humor and psychosis in an atypical depression].
Sicot R
Encephale; 2005 Oct; 31 Pt 2():S11-3. PubMed ID: 16673695
[No Abstract] [Full Text] [Related]
11. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
Blumberger DM; Mulsant BH; Emeremni C; Houck P; Andreescu C; Mazumdar S; Whyte E; Rothschild AJ; Flint AJ; Meyers BS
J Psychiatr Res; 2011 Jul; 45(7):896-901. PubMed ID: 21300377
[TBL] [Abstract][Full Text] [Related]
12. Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study.
Song J; Mulsant BH; Sanches M; Alexopoulos GS; Marino P; Meyers BS; Rothschild AJ; Voineskos AN; Whyte EM; Flint AJ; Gerretsen P;
J Affect Disord; 2023 Mar; 325():29-34. PubMed ID: 36592671
[TBL] [Abstract][Full Text] [Related]
13. A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.
Deligiannidis KM; Rothschild AJ; Barton BA; Kroll-Desrosiers AR; Meyers BS; Flint AJ; Whyte EM; Mulsant BH;
J Clin Psychiatry; 2013 Oct; 74(10):1003-9. PubMed ID: 24229753
[TBL] [Abstract][Full Text] [Related]
14. Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).
Østergaard SD; Rothschild AJ; Flint AJ; Mulsant BH; Whyte EM; Vermeulen T; Bech P; Meyers BS
J Affect Disord; 2016 Jan; 190():111-114. PubMed ID: 26496016
[TBL] [Abstract][Full Text] [Related]
15. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
[TBL] [Abstract][Full Text] [Related]
16. Stabilization treatment of remitted psychotic depression: the STOP-PD study.
Bingham KS; Meyers BS; Mulsant BH; Rothschild AJ; Whyte EM; Banerjee S; Artis AS; Alexopoulos GS; Flint AJ;
Acta Psychiatr Scand; 2018 Sep; 138(3):267-273. PubMed ID: 29959765
[TBL] [Abstract][Full Text] [Related]
17. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.
Blumberger DM; Mulsant BH; Kanellopoulos D; Whyte EM; Rothschild AJ; Flint AJ; Meyers BS
J Clin Psychopharmacol; 2013 Jun; 33(3):391-7. PubMed ID: 23609383
[TBL] [Abstract][Full Text] [Related]
18. Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II.
Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Mulsant BH; Rudorfer MV; Marino P;
BMC Psychiatry; 2013 Jan; 13():38. PubMed ID: 23351522
[TBL] [Abstract][Full Text] [Related]
19. An open trial of olanzapine in the treatment of patients with psychotic depression.
Nelson EB; Rielage E; Welge JA; Keck PE
Ann Clin Psychiatry; 2001 Sep; 13(3):147-51. PubMed ID: 11791952
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
